Therefore, as we demonstrated in the mouse model of allergic asthma treated with SOCS3 siRNA intranassally [14], SOCS3 up-regulated expression in asthma has to be controlled, in this case by gene silencing in order to restore SOCS3 homeostatic levels. This evidence concerns the gene SOCS3 and asthma.